Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
Background: There is sufficient evidence of the high prevalence of obesity in schizophrenia (SZ) compared to the general population. Previous studies have reported that weight gain correlated with the response to antipsychotics in patients with SZ. Nonetheless, the relationship between body mass ind...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Sprog: | English |
| Udgivet: |
Frontiers Media S.A.
2023-11-01
|
| Serier: | Frontiers in Pharmacology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1264591/full |